| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5976573 | CHATTEM SANOFI | Aqueous-based pharmaceutical composition |
Jul, 2016
(7 years ago) | |
| US7977045 | CHATTEM SANOFI | Aqueous-based pharmaceutical composition |
Jul, 2016
(7 years ago) | |
| US6143329 | CHATTEM SANOFI | Aqueous-based pharmaceutical composition |
Jul, 2016
(7 years ago) | |
Nasacort Allergy 24 Hour is owned by Chattem Sanofi.
Nasacort Allergy 24 Hour contains Triamcinolone Acetonide.
Nasacort Allergy 24 Hour has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Nasacort Allergy 24 Hour are:
- US5976573
- US7977045
- US6143329
Nasacort Allergy 24 Hour was authorised for market use on 20 May, 1996.
Nasacort Allergy 24 Hour is available in spray, metered;nasal dosage forms.
The generics of Nasacort Allergy 24 Hour are possible to be released after 03 July, 2016.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Sep 19, 2011 |
Drugs and Companies using TRIAMCINOLONE ACETONIDE ingredient
Market Authorisation Date: 20 May, 1996
Treatment: NA
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
NASACORT ALLERGY 24 HOUR family patents
